
News
Cellply Joins the NextGenNK Competence Center at Karolinska Institutet to Accelerate Next-Generation Cancer Immunotherapies
18 June 2026

In this webinar Dr. Francesco Imperatore, Field Application Specialist at Cellply, discusses a novel approach to uncover hidden killing activity within a cell therapy population and reveal which subsets have the potential to exhibit a dominant role in anti-tumor activity.
Duration: 30 mins
Highlights:
